Debate over details of US biosimilar pathway continues to rage.
Jeffrey L
JL
Fox
D059451:Biosimilar Pharmaceuticals / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000191:economics; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration / Q000191:economics / Q000331:legislation & jurisprudence
D059451:Biosimilar Pharmaceuticals